The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer
Year: 2020
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Malignant pleural effusion (MPE)-macrophage (Mφ) of lung cancer patients within unique M1/M2 spectrum showed plasticity in M1-M2 transition. The M1/M2 features of MPE-Mφ and their significance to patient outcomes need to be clarified; furthermore, whether M1-repolarization could benefit treatment remains unclear. METHODS: Total 147 stage-IV lung adenocarcinoma patients undergoing MPE drainage were enrolled for profiling and validation of their M1/M2 spectrum. In addition, the MPE-Mφ signature on overall patient survival was analyzed. The impact of the M1-polarization strategy of patient-derived MPE-Mφ on anti-cancer activity was examined. RESULTS: We found that MPE-Mφ expressed both traditional M1 (HLA-DRA) and M2 (CD163) markers and showed a wide range of M1/M2 spectrum. Most of the MPE-Mφ displayed diverse PD-L1 expression patterns, while the low PD-L1 expression group was correlated with higher levels of IL-10. Among these markers, we identified a novel two-gene MPE-Mφ signature, IL-1β and TGF-β1, representing the M1/M2 tendency, which showed a strong predictive power in patient outcomes in our MPE-Mφ patient cohort (N = 60, p = 0.013) and The Cancer Genome Atlas Lung Adenocarcinoma dataset (N = 478, p < 0.0001). Significantly, β-glucan worked synergistically with IFN-γ to reverse the risk signature by repolarizing the MPE-Mφ toward the M1 pattern, enhancing anti-cancer activity. CONCLUSIONS: We identified MPE-Mφ on the M1/M2 spectrum and plasticity and described a two-gene M1/M2 signature that could predict the outcome of late-stage lung cancer patients. In addition, we found that "re-education" of these MPE-Mφ toward anti-cancer M1 macrophages using clinically applicable strategies may overcome tumor immune escape and benefit anti-cancer therapies.
Source: Cancer Immunology Immunotherapy
Institutions: National Taiwan University, Institute of Statistical Science, Academia Sinica, Academia Sinica, National Taiwan University Hospital, Soochow University, Institute of Physics, Academia Sinica, National Chung Hsing University, Taichung Veterans General Hospital, Chung Shan Medical University Hospital, National Yang Ming University, University of California, Los Angeles
Language: English
Topic: Immune cells in cancer
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: malignant pleural effusion, tumor-associated macrophages, macrophage polarization, macrophage plasticity, lung adenocarcinoma, stage IV lung cancer, IL-1β, TGF-β1, macrophage repolarization, β-glucan, interferon-gamma, PD-L1, IL-10, prognostic signature, tumor immune evasion, overall survival
Open Access status: hybrid
Estimated APC paid: $3,860
Awards: Developing Reconstituted 3-D Platforms to Study Architecture-Dependent Cell-Cell Interactions in Tumor Microenvironments(III), G1555286449, G16294818, Systemic Safety Allograft Strategies for Cell Therapeutic Product Development: Targeting Unmet Medical Need Human Chronic Inflammatory Disease - Diabetes Mellitus /Decubitus Wound, Severe Burn, and Multiple Sclerosis( III ), To Study the Heterogeneity of Air Pollutant Particle Matters Pm2.5 and the Synergistic Mutagenicity and Carcinogenicity in Lung Progenitor Cells, G7317255252
OpenAlex ID: W3105687100
